Phadia's Financial Acquisition

Phadia raised a round of funding on November 16, 2006. Investors include Cinven.

Phadia develops, manufactures and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. In May 2011, Phadia was acquired by …

Articles about Phadia's Financial Acquisition: